TY - JOUR KW - Child KW - Humans KW - Infant KW - Incidence KW - Vaccines, Conjugate KW - *Otitis Media/epidemiology/prevention & control KW - Pneumococcal Vaccines KW - Streptococcus pneumoniae KW - England/epidemiology KW - *Pneumococcal Infections/epidemiology/prevention & control KW - Acute otitis media KW - Pneumococcal conjugate vaccine KW - Recurrent AOM KW - United Kingdom AU - S. Mohanty AU - B. Podmore AU - Cuñado Moral AU - T. Weiss AU - I. Matthews AU - E. Sarpong AU - I. Méndez AU - N. Qizilbash AD - Merck & Co., Inc, Center for Observational and Real-World Evidence (CORE), Rahway, NJ, USA. salini.mohanty@merck.com. OXON Epidemiology Ltd, Epidemiology & Statistics, Madrid, Spain. Merck & Co., Inc, Center for Observational and Real-World Evidence (CORE), Rahway, NJ, USA. MSD (UK) Ltd, Value, Access and Devolved nations (VAD), London, UK. Merck & Co., Inc., Real-world Data Analytics and Innovation (RDAI), Rahway, NJ, USA. AN - 36717794 BT - BMC Public Health C2 - PMC9885604 DO - 10.1186/s12889-023-14982-8 DP - NLM ET - 2023/01/31 LA - eng M1 - 1 N1 - 1471-2458 Mohanty, Salini Podmore, Bélène Cuñado Moral, Ana Weiss, Thomas Matthews, Ian Sarpong, Eric Méndez, Ignacio Qizilbash, Nawab Journal Article Observational Study England BMC Public Health. 2023 Jan 30;23(1):201. doi: 10.1186/s12889-023-14982-8. PY - 2023 SN - 1471-2458 EP - 201 T2 - BMC Public Health TI - Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England VL - 23 ER -